Title |
Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity
|
---|---|
Published in |
Frontiers in immunology, March 2018
|
DOI | 10.3389/fimmu.2018.00401 |
Pubmed ID | |
Authors |
Erica J. Brodie, Simona Infantino, Michael S. Y. Low, David M. Tarlinton |
Abstract |
Systemic lupus erythematosus (SLE) is a progressive autoimmune disease characterized by increased sensitivity to self-antigens, auto-antibody production, and systemic inflammation. B cells have been implicated in disease progression and as such represent an attractive therapeutic target. Lyn is a Src family tyrosine kinase that plays a major role in regulating signaling pathways within B cells as well as other hematopoietic cells. Its role in initiating negative signaling cascades is especially critical as exemplified by Lyn-/-mice developing an SLE-like disease with plasma cell hyperplasia, underscoring the importance of tightly regulating signaling within B cells. This review highlights recent advances in our understanding of the function of the Src family tyrosine kinase Lyn in B lymphocytes and its contribution to positive and negative signaling pathways that are dysregulated in autoimmunity. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 29% |
United States | 1 | 14% |
Switzerland | 1 | 14% |
Unknown | 3 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 71% |
Scientists | 1 | 14% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 64 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 9 | 14% |
Researcher | 8 | 13% |
Student > Ph. D. Student | 7 | 11% |
Student > Doctoral Student | 6 | 9% |
Student > Master | 5 | 8% |
Other | 10 | 16% |
Unknown | 19 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 12 | 19% |
Medicine and Dentistry | 11 | 17% |
Biochemistry, Genetics and Molecular Biology | 8 | 13% |
Chemistry | 5 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Other | 4 | 6% |
Unknown | 21 | 33% |